(Q41283995)

English

Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 September 2017

Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists (English)

1 reference

Europe PubMed Central

29 September 2017

0 references

desensitization

1 reference

based on heuristic

inferred from title

Theodore J. Torphy

1

object named as

Torphy TJ

0 references

author name string

Zhou HL

2

1 reference

Europe PubMed Central

29 September 2017

Foley JJ

3

1 reference

Europe PubMed Central

29 September 2017

Sarau HM

4

1 reference

Europe PubMed Central

29 September 2017

Manning CD

5

1 reference

Europe PubMed Central

29 September 2017

Barnette MS

6

1 reference

Europe PubMed Central

29 September 2017

language of work or name

0 references

publication date

1 October 1995

1 reference

Europe PubMed Central

29 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

29 September 2017

270

1 reference

Europe PubMed Central

29 September 2017

23598-23604

1 reference

Europe PubMed Central

29 September 2017

40

1 reference

Europe PubMed Central

29 September 2017

Isolation of a cDNA encoding a human rolipram-sensitive cyclic AMP phosphodiesterase (PDE IVD)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Endogenous catecholamines and asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Questions about inhaled beta 2-adrenoceptor agonists in asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Regulation and function of cyclic nucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Regulation of phosphodiesterase synthesis: requirement for cyclic adenosine monophosphate-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Modulation of inflammation and immunity by cyclic AMP.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Hormonal regulation of cyclic nucleotide phosphodiesterases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Expression and regulation of human and rat phosphodiesterase type IV isogenes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Histamine induced elevation of cyclic AMP phosphodiesterase activity in human monocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

The interaction of alpha-human atrial natriuretic peptide (ANP) with salbutamol, sodium nitroprusside and isosorbide dinitrate in human bronchial smooth muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Regular Inhaled Beta-Adrenergic Agonists in the Treatment of Bronchial Asthma: Beneficial or Detrimental?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Inhibitors of protein kinase C selectively enhanced leukotriene D4-induced calcium mobilization in differentiated U-937 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.40.23598

21 January 2018

Identifiers

10.1074/JBC.270.40.23598

1 reference

Europe PubMed Central

29 September 2017

1 reference

Europe PubMed Central

29 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41283995&oldid=2095811103"